Eledon Pharmaceuticals Inc

NAS:ELDNHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$2.13−6.17%At closeAt close · Sat 17 Oct · ≈ AED 7.82 · Market cap $173.09M · Next earnings Fri 13 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Return on equity	−12.0%	−21.0%	−104.5%	−1,616.8%	−30.6%	−56.3%	−56.3%	+0.0 pts
Return on assets	−11.6%	−20.2%	−94.8%	−130.8%	−20.4%	−27.0%	−27.0%	+0.0 pts
Return on capital employed	−9.5%	−22.2%	−102.4%	−50.5%	−42.6%	−55.3%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.1×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	0.1%	0.5%	0.8%	0.4%	0.5%	0.4%	—	—
Interest coverage	−1.9×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	46.6×	20.1×	9.2×	14.4×	12.4×	7.4×	7.4×	+0.0%
Quick ratio	46.6×	20.1×	9.2×	14.4×	12.4×	7.4×	—	—
Cash ratio	46.0×	19.3×	8.7×	1.2×	1.8×	1.2×	1.2×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Receivables turnover	0.0×	—	—	—	—	0.0×	—	—
Dividend payout	−0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.